To see all protocols that comply with the WHO Essential Medicine List 

Reference committee chairs

Current chairs and co-chairs


Cellular therapies co-chair: Dr Jason Butler

2023 - present 

Dr Jason Butler is a part-time senior staff haematologist with the Bone Marrow Transplant Unit, Royal Brisbane and Women’s Hospital and Sunshine Coast University Hospital, and a visiting medical officer with Icon Cancer Care. His major interests are in blood and marrow transplantation, lymphoma, and myeloma.

Jason is also current co-chair of the eviQ Blood and marrow transplant reference committee, and is past chair of the eviQ Haematology reference committee and a past interim chair of the eviQ Cellular therapies reference committee.


Cellular therapies co-chair: Vinay Vanguru

2023 - present 

Dr Vinay Vanguru is a haematology staff specialist at Royal Prince Alfred Hospital. He completed his training at Liverpool Hospital and Royal Prince Alfred Hospital in clinical and laboratory haematology. His major clinical and research interests include lymphoma and bone marrow transplantation. He also has a keen interest in electronic management of health information and medication management.

Vinay is past co-chair of the eviQ Haematology reference committee. 


Medical oncology co-chair: A/Prof Peter Grimison

2021 - present

Peter Grimison is senior staff specialist in medical oncology and Director of Physician Training at the Chris O'Brien Lifehouse in Sydney; visiting medical officer at Royal Prince Alfred Hospital; and Clinical Associate Professor at the University of Sydney. His major clinical and research interests relate to  testicular cancer, upper gastro-intestinal cancer, sarcoma, and supportive care interventions. He is study chair of a number of national and international clinical trials, and also serves as a member of the Australian Government Pharmaceutical Benefits Advisory Committee.


Medical oncology co-chair: Dr Brett Hamilton

2021 - present

Dr Brett Hamilton is a VMO medical oncologist at Albury Wodonga Health and Northeast Health Wangaratta and a conjoint lecturer at the University of New South Wales.  Brett has a strong interest in the delivery of oncology services in regional and rural settings.  He is currently completing a Masters in Medical Statistics.  Brett moved to Albury as a medical oncologist in 2019 and treats all solid malignancies, with special interests in cancers of the lung, head and neck and genitourinary tract. 


Medical oncology co-chair: A/Prof Hao-Wen Sim

2023 - present

A/Prof Hao-Wen Sim is a medical oncologist based at The Kinghorn Cancer Centre and Chris O'Brien Lifehouse in Sydney. Additionally, he holds the position of Clinical Lead at the NHMRC Clinical Trials Centre in Sydney. His areas of expertise encompass neuro-oncology, upper gastrointestinal oncology and clinical trials. Hao-Wen earned a Master of Biostatistics degree from The University of Sydney, where he was awarded the Biostatistics Collaboration of Australia Star Graduate Award, Judy Simpson Biostatistics Scholarship, Les Irwig General Epidemiology Award and the Australasian Epidemiological Association Top Student Prize. Hao-Wen also completed a neuro-oncology fellowship at The Princess Margaret Cancer Centre in Toronto, Canada.


Haematology co-chair: A/Prof Tara Cochrane

2021 - present

A/Prof Cochrane is a senior haematologist, with expertise in lymphoma at Gold Coast University Hospital (GCUH) with an honorary appointment at Griffiths University. She is a productive researcher with numerous peer reviewed articles, which include leading the development of the Australian Clinical Practice Statement in Hodgkin Lymphoma. She has been a principal investigator in many lymphoma clinical trials and has been successful in obtaining more than 3 million dollars in grant funding for lymphoma related research. She established and is the programme director for the autologous transplant unit at GCUH. A/Prof is a member of the Australasian Lymphoma and Leukaemia Group (ALLG) and was appointed to their Scientific Advisory Committee in 2019. She also co-chairs the lymphoma working group, leading the strategic direction of the lymphoma research portfolio. She has also contributed to the development of the national optimal care pathways in lymphoma. A/Prof Cochrane trained in Melbourne and then undertook a fellowship in lymphoma and transplant in Toronto and more recently an observership at MD Anderson Cancer Centre in CAR T cells. She has a large clinical practice in predominantly malignant haematology and transplant.


Haematology co-chair: Dr Gaurav Sutrave

2023 - present

Dr Gaurav Sutrave is a staff specialist haematologist and transplant and cell therapies physician at Westmead Hospital. He completed his PhD in the field of gene modified cell therapies for fungal infections, followed by a 2 year transplant and cell therapies fellowship at Westmead Hospital. Along with his current clinical role, he is continuing his post-doctoral research in exploring the development of novel adoptive cell therapies to treat relapsed haematological malignancies and infectious complications in immune suppressed patients. He is currently closely involved with several local and multicentre cell therapy investigator initiated clinical trials. Dr Sutrave is a clinical lecturer at the University of Sydney, as well as a member of the International Society for Cell and Gene Therapies Immuno- and Gene Therapy Committee.


Blood and marrow transplant chair: Dr Duncan Purtill

2020 - present

Duncan Purtill is a consultant haematologist at Fiona Stanley Hospital, WA.  He trained in WA and undertook fellowships at Hôpital Saint Louis, Paris, and Memorial Sloan Kettering Cancer Centre, New York.  His interests are in stem cell transplantation and cellular therapies, and in promoting the role of quality management and patient registries in clinical practice.  


Blood and marrow transplant co-chair: Jason Butler

2022 - present 

Dr Jason Butler is a part-time senior staff haematologist with the Bone Marrow Transplant Unit, Royal Brisbane and Women’s Hospital and Sunshine Coast University Hospital, and a visiting medical officer with Icon Cancer Care. His major interests are in blood and marrow transplantation, lymphoma, and myeloma.

Jason is also current co-chair of the eviQ Cellular therapies reference committee, and is past chair of the eviQ Haematology reference committee and a past interim chair of the eviQ Cellular therapies reference committee.


Cancer genetics co-chair: Dr Minmin Li

2023 - present

Dr Minmin Li is a dual trained medical oncologist and cancer geneticist who works as a Staff Specialist at Hereditary Cancer Centre, Prince of Wales Hospital. Minmin is actively involved in clinical trials and in the teaching of genetic and non-genetic health professionals. Her research areas include hereditary endocrine tumour syndromes, quality improvement and patient communication.   


Cancer genetics co-chair: Dr Emilia Ip

2022 - present

Dr Emilia Ip completed a Bachelor of Medical Science with Honours in Biochemistry before commencing a combined MBBS/PhD program at the University of Sydney. After attaining Fellowship with the Royal Australian College of Physicians as a Medical Oncologist, she commenced Cancer Genetics training, which was generously supported by a training grant provided by the Cancer Institute NSW. Since 2020, Emilia has been working as a Staff Specialist in Cancer Genetics at Liverpool Hospital, which services individuals and families throughout South Western Sydney. Aside from clinical work, Emilia has been very involved in the educating health professionals ranging from medical students to specialists, regarding hereditary cancer predisposition and genetics.


Cancer genetics co-chair: Linda Warwick

2022 - present

Linda Warwick is senior genetic counsellor and manager of the ACT Genetic Service for ACT Health. Linda has worked in cancer genetic counselling for more than 20 years. Linda has been committed to developing and providing patient consultations through telehealth platforms. She has a strong commitment to equitable and accessible provision of telehealth cancer genetic consultations for patients in regional settings.


Cancer genetics paediatric co-chair: Dr Kanika Bhatia

2019 - present

Dr Kanika Bhatia is a paediatric oncologist at the Children’s Cancer Centre in the Royal Children’s Hospital (RCH), Melbourne. Her major clinical and research interests are in solid and brain tumours, paediatric cancer genetics as well as palliative and supportive care. She is the clinical lead for a multi-disciplinary paediatric cancer genetics program in the RCH.


Cancer genetics paediatric co-chair: Dr Catherine Kiraly-Borri

2023 - present

Catherine Kiraly-Borri is a clinical geneticist at Genetic Services of Western Australia. She trained in Switzerland and Australia. Her main interests are cancer genetics, particularly paediatric cancer genetics, and improving delivery of genetic services to rural area.  Catherine has an interest in providing genetic education to health professionals, medical students and the general community and her research focusses on paediatric and adult surveillance clinics for families with inherited cancer predispositions. 


Radiation oncology co-chair: Dr Georgia Harris

2021 - present

Georgia Harris is a Radiation Oncology Staff Specialist at the Chris O’Brien Lifehouse, and a visiting Radiation Oncologist at Royal Prince Alfred Hospital. Georgia specialises predominantly in breast cancer treatment, and works as part of the Chris O’Brien Lifehouse and Strathfield Breast Centre multi-disciplinary teams providing tailored treatment to patients. She also has a keen interest in the treatment of CNS malignancies and metastatic disease, including proficiency in the use of SRS and SBRT. Georgia completed her training at Royal North Shore Hospital prior to undertaking her fellowship at the Princess Margaret Cancer Centre in Toronto, Canada and has published in multiple peer-reviewed journals and presented at local and international meetings. She is passionate about patient-centred care as well as technical innovation and the provision of high quality radiotherapy treatment. Georgia is actively involved in clinical trials and in the teaching of radiation oncology trainees and medical students at the University of Sydney Central Clinical School, and has been involved in developing guidelines for breast cancer and palliative radiotherapy at the Cancer Institute NSW.


Radiation oncology chair: Dr Tristan Shaw

2023 - present

Dr Tristan Shaw is a Radiation Oncologist in the Bundaberg and Fraser Coast region with a passion for regional radiation oncology. He strongly advocates for regional patients to have a choice for their treatment to be delivered close to their home with the same quality and technology afforded to patients in metro regions. As a regional radiation oncologist, he believes it is vital for specialists in these regions to be across the latest evidence-based guidelines in all tumour subsites. He is proud of the stereotactic program developed in Bundaberg and the service he can offer regional patients. Tristan has been involved in the radiation oncology speciality since 2004. First as a radiation therapist, then pursuing radiation oncology training in regional NSW and tertiary centres in Brisbane. He has developed protocols and guidelines during his time as a radiation therapist and now with eviQ. Tristan encourages radiation oncology education in his region and presents at community events for local medical officers and the general public. He is also passionate about registrar training and runs Phase 2 education programs.


Radiation oncology chair: Dr Ee Siang Choong

2023 - present

Dr Ee Siang Choong is a radiation oncologist at the Austin Radiation Oncology Centre, Melbourne. He completed his training at St James Institute of Oncology, Leeds, UK. In Australia he has worked at metropolitan and regional centres including appointments at Chris O’Brien Lifehouse (COBLH) and Ballarat Radiation Oncology Cancer Centre. His major clinical and research interests relate to lung cancer, head and neck cancer and stereotactic radiosurgery. Ee Siang has a special focus on research and clinical trials evidenced by multiple publications and presentations at international conferences ESTRO and ASTRO, and his role as Director of Research, radiation oncology at COBLH. He is committed to education and held the position of Director of Training, RANZCR Radiation Oncology Registrar trainee programme at COBLH. Ee Siang has been involved with protocol reviews for eviQ and has played an active role in developing clinical programs including for stereotactic liver metastases.


Past chairs and co-chairs


Radiation oncology co-chair: Dr Ben Chua

2019 - 2023

Dr Ben Chua is a radiation oncologist and director of registrar training at the Royal Brisbane & Women’s Hospital, and visiting radiation oncologist at GenesisCare Rockhampton. He completed his training in Queensland and regional New South Wales, with a specialty fellowship in head and neck cancer. He is an Associate Professor at the University of Queensland with an active academic portfolio, including being involved in clinical trials and supervision of higher degree students. He has participated in developing practice guidelines within his workplaces and through eviQ, and believes that all patients, including those in regional areas, should have access the highest standard of evidence-based and multidisciplinary care. 


Haematology co-chair: Dr Vinay Vanguru

2019 - 2023

Dr Vinay Vanguru is a haematology staff specialist at Royal Prince Alfred Hospital. He completed his training at Liverpool Hospital and Royal Prince Alfred Hospital in clinical and laboratory haematology. His major clinical and research interests include lymphoma and bone marrow transplantation. He also has a keen interest in electronic management of health information and medication management.


Medical oncology co-chair: Dr Kate Webber

2019 - 2023

Dr Kate Webber is a medical oncologist with a keen interest in gynaecological oncology, cancer survivorship and clinical trials. She is an adjunct senior lecturer at Medicine Monash Health. Previously Kate held staff specialist appointments in medical oncology at Prince of Wales Hospital and the Royal Hospital for Women in Sydney, as well as an honorary appointment at Sydney Children’s Hospital. At Prince of Wales Hospital she also served as Clinical Superintendent for Medicine and co-Director of Advanced Physician Training, as well as convenor of the UNSW Human Research Ethics Advisory Panel (Biomedical).


Radiation oncology co-chair: Dr Penny Mackenzie

2019 - 2023

Dr Penny Mackenzie is a radiation oncologist at St Andrew’s Hospital, Toowoomba (Icon). Following her speciality training in Brisbane, she completed a breast cancer fellowship at the Princess Margaret Hospital in Canada. Her subspecialty interests include breast cancer, head and neck cancer, skin cancer and melanoma. Penny’s research interests include geriatric oncology. Penny is also committed to the teaching and training of junior doctors.


Cancer genetics chair: Dr Nicola K Poplawski

2014 - 2018 (adult)
2018 - 2023 (paediatrics)

Dr Nicola Poplawski is a paediatrician and clinical geneticist who trained in New Zealand (the University of Otago), Australia (the Women’s and Children’s Hospital in Adelaide) and Canada (the Hospital for Sick Children, Toronto). She is interested and has experience in genetic education for the public, for families and for healthcare professionals. Her research focuses on clinical aspects of inherited diseases, including familial cancer. Dr Poplawski works as a clinical geneticist in the Adult Genetics Unit located at the Royal Adelaide Hospital in South Australia.


Cancer genetics chair: Dr Helen Mar Fan

2018 - 2022

Dr Helen Mar Fan is a dual trained medical oncologist and cancer geneticist who works in the cancer service at Genetic Health Queensland. She has an interest in the education of non-genetic health professionals in the ordering and interpreting of genetic tests and in the development of evidence-based guidelines for genetic testing and risk management for individuals with familial cancer predisposition syndromes.


Blood and marrow transplant chair: Dr Ed Morris

2018 - 2022

Dr Ed Morris is a senior staff specialist at the Townsville Hospital and a visiting medical officer with ICON Cancer Care. He spent three years at the Queensland Institute of Medical Research investigating the immunological processes following allogeneic stem cell transplantation.


Cellular Therapies interim chair: Dr Jason Butler

2021 - 2022

Dr Jason Butler is a part-time senior staff haematologist with the Bone Marrow Transplant Unit, Royal Brisbane and Women’s Hospital and Sunshine Coast University Hospital, and a visiting medical officer with Icon Cancer Care. His major interests are in blood and marrow transplantation, lymphoma, and myeloma.


Cancer genetics co-chair: Rachel Williams

2018 - 2022

Rachel Williams is the Senior Genetic Counsellor Network Clinical Lead for the South Eastern Sydney Local Health District, based at the Prince of Wales Hospital Hereditary Cancer Centre. She has more than 17 years experience in cancer genetic counselling. Rachel has an interest in providing evidence-based information to health professionals, patients and their families to improve patient care. Rachel's research interests are in improved patient access to cancer genetics services and hereditary bowel cancer conditions.


Medical oncology co-chair: Dr Brian Stein

2017 - 2021

Dr Brian Stein is a medical oncologist who trained in Australia and the USA. He works at the Adelaide Cancer Centre and in the Department of Medical Oncology at the Royal Adelaide Hospital. He is affiliated with the University of Adelaide where he has been recognised for his teaching excellence. He has a long-standing subspecialty interest in malignancies of the head and neck and treatment of cancer in the elderly.


Medical oncology co-chair: Dr Rachel Wong

2017 - 2021

Dr Rachel Wong is Deputy Director of Oncology at Eastern Health and a medical oncologist at Epworth Eastern. Her major clinical and research interests are in gastrointestinal and lung cancers. After completing training in Melbourne, Rachel completed a clinical research fellowship at The Royal Marsden Hospital, London (Gastrointestinal and Lymphoma unit). She is an adjunct senior lecturer at Monash University, a Clinical Research Fellow at the Walter & Eliza Hall Institute of Medical Research and has had significant involvement with medical oncology training at a state and national level.


Haematology chair: Dr Jason Butler

2017 - 2021

Dr Jason Butler is a part-time senior staff haematologist with the Bone Marrow Transplant Unit, Royal Brisbane and Women’s Hospital and Sunshine Coast University Hospital, and a visiting medical officer with Icon Cancer Care. His major interests are in blood and marrow transplantation, lymphoma, and myeloma.


Radiation oncology chair: Dr Jonathan Tomaszewski

Chair 2019 - 2021, Co-chair 2017 - 2019

Dr Jonathan Tomaszewski is a radiation oncologist at the Ballarat Austin Radiation Oncology Centre (BAROC). He trained at the Peter MacCallum Cancer Centre in Melbourne, where he also completed a subspecialty fellowship in head and neck cancer. He now works as a generalist radiation oncologist with a focus on providing world-class, evidence-based care for regional cancer patients close to home. Jonathan has an interest in radiobiology and is a lecturer in radiation and cancer biology for the Victorian/Tasmanian Training Network.


Blood and marrow transplant chair: Dr Matthew Wright

Chair 2018 - 2020, Co-chair 2016 - 2017

Dr Matthew Wright is a haematologist and head of department at Fiona Stanley Hospital in Perth. His clinical interests include myeloma, AML and MDS. After completing training in Sydney, Matt completed a BMT fellowship in Vancouver and is a member of the BMT program at FSH.


Medical oncology chair: A/Prof Craig Lewis

Chair 2017 - 2019, Co-chair 2015 - 2017

Dr Craig Lewis is a conjoint associate professor at the University of New South Wales and senior staff specialist in the Department of Medical Oncology at Prince of Wales Hospital in Sydney. His major clinical and research interests include breast, lung, and head and neck cancer, and the management of chemotherapy-induced nausea and vomiting.


Haematology chair: Dr Nada Hamad

2017 - 2019

Dr Nada Hamad is staff specialist clinical, bone marrow transplant and laboratory haematologist at St Vincent’s Hospital. She completed postgraduate fellowships in haematopoietic stem cell transplantation and lymphoma at the Princess Margaret Cancer Centre in Toronto, Canada. She has a strong interest in clinical trials and has a specialist certificate in clinical research (Oncology) from the University of Melbourne and is an active member of the Australian Leukaemia and Lymphoma group (ALLG). Her research interests include haematological malignancy, GVHD management and the implementation and delivery of evidence-based medicine. She is also a senior lecturer at the University of Sydney and the University of New South Wales and examiner for the Royal Australasian College of Physicians.


Radiation oncology chair: Dr Carmen Hansen

Chair 2017 - 2019, Co-chair 2015 - 2017

Carmen is a radiation oncologist at the Mid North Coast Cancer Institute (MNCCI) in Port Macquarie, where she specialises in the management of breast, gynaecological and urological malignancies. She is actively involved in developing and implementing improved technology in the treatment of breast cancer at MNCCI. Carmen is director of the Northern NSW Training Network at the Royal Australian and New Zealand College of Radiologists (RANZCR).


Blood and marrow transplant chair: Dr Sharon Avery

Chair 2016 - 2018, Co-chair 2014 - 2015

Dr Sharon Avery is a senior staff specialist in the Malignant Haematology and Stem Cell Transplantation Service at the Alfred Hospital, Melbourne. She is actively involved in the development of protocols and guidelines for the treatment of blood cancers and has a particular interest in the management of late effects in long term survivors of transplantation.


Cancer genetics co-chair: Sian Greening

2014 - 2018

Sian Greening is a certified genetic counsellor with a background in palliative care nursing and a Masters in Clinical Science (lifestyle medicine). In 2005 she was employed to set-up the Hereditary Cancer Genetic Counselling Service for Illawarra and Shoalhaven Health District Clinic, where she continues to work as the senior genetic counsellor, running many quality improvement and research projects.


Radiation oncology chair: Dr Michael Ng

2015 - 2017, Co-chair 2013 - 2015

Dr Michael Ng is a radiation oncologist working at Radiation Oncology Victoria (ROV). He completed his specialist training at the Peter MacCallum Cancer Centre and spent his fellowship year at the Royal Marsden Hospital in the UK. He returned to Melbourne as a consultant in head and neck, and GI malignancies for two years. After two years, he joined ROV in 2009. His current interests and research includes development of clinical practice guidelines, advanced application of intensity modulated radiotherapy and interest in use of new radiation technologies.


Haematology chair: Dr Adam Bryant

Chair 2015 - 2017, Co-chair 2014 - 2015

Dr Adam Bryant did his haematology training at St Vincent's Hospital in Sydney, having originally done his medical school at the University of Queensland. He went on to do his PhD studies under the supervision of Professor David Ma at the AMR in Darlinghurst. This was a molecular biology basic science project entitled "The Role of MicroRNAs in Acute Myeloid Leukaemia". The PhD was successfully awarded in late 2012. While writing up his PhD he did a clinical fellowship at the Vancouver General Hospital as the Leukaemia and BMT fellow. The benefit of this role was intense clinical exposure to AML and allogeneic transplant which are done at this unit for the entire British Columbia. He has been a staff specialist at Liverpool since May 2012 which commenced an allogeneic BMT program at this time.


Haematology chair: Dr Amanda Johnston

2013 - 2015

Dr Amanda Johnston is senior staff specialist in haematology at Westmead Hospital.


Blood and marrow transplant chair: Prof Ian Kerridge

2008 - 2015, Haematology chair 2007 - 2008

Professor Ian Kerridge is a staff haematologist and BMT physician at Royal North Shore Hospital in Sydney. Prior to this he worked at Westmead Hospital, Sydney and the Royal Free and University College Hospital in London. His major current research interests are ICU outcomes in haematology patients, myeloma and late effects following BMT.


Haematology chair: Dr Michael Harvey

2013, co-chair 2012

Dr Michael Harvey is senior staff specialist in haematology at Liverpool Hospital. He has had a longstanding interest in post graduate medical education and has served previously as chairman of the Board of Education with the Royal College of Pathologists of Australasia, as well as coordinator of advanced training and vice president of the Haematology Society of Australia and New Zealand (HSANZ). His research interests are mainly centred around clinical trials in both malignant and non-malignant haematology, as well as the molecular basis of haematological diseases.


Haematology chair: Dr Tim Brighton

2009 - 2013

Dr Tim Brighton is a senior staff haematologist at Prince of Wales Hospital in Sydney. Tim has focused during his career on clinical research and participates in numerous malignant and non-malignant sponsored and investigator-initiated clinical research studies. Main clinical and research interests include platelet disorders, bleeding disorders, and the investigation and management of thrombosis.


Haematology chair: Dr Cecily Forsythe

2006 - 2008

Dr Cecily Forsyth has worked as a clinical haematologist on the Central Coast of NSW for over 15 years. She has extensive clinical trial involvement and is passionate about improving patients' access to information and education.MNCCI.


Primary health care chair: Dr Tony Hobbs

2008 - 2013

Dr Hobbs is a GP obstetrician from Cootamundra on the south-west slopes of NSW, where he has been involved in the establishment of an innovative integrated primary care service. He has worked in his local community for 19 years. Dr Hobbs is committed to improving access to health care and reducing inequitable health outcomes through a comprehensive primary health care approach.


Radiation oncology co-chair: A/Prof Andrew Kneebone

2007 - 2011

Associate Professor Andrew Kneebone is a senior staff specialist in radiation oncology at Royal North Shore Hospital Sydney and clinical associate professor with the University of Sydney. He has subspecialty interests in gastrointestinal and genitourinary malignancies with a strong commitment to research and education. He has been the principal investigator for two completed randomised trials in prostate cancer, is the trial co-chair for an NHMRC funded international trial of post prostatectomy radiotherapy, is associated with more than $4,000,000 in external funding and is on the trial management committee for five national studies. He is an author on more than 40 peer-reviewed publications and is on numerous state and national committees.


Radiation oncology chair: Dr Andrew Last

2013 - 2015, Co-chair 2012 - 2013

Dr Andrew Last trained in medicine in Oxford and spent some time in neuroscience research in Oxford and New York. In 1994 he commenced oncology training at the Royal Marsden Hospital in London and subsequently worked for 10 years in Southampton, UK as a clinical oncologist, giving both radiotherapy and chemotherapy. In 2008 he joined the North Coast Cancer Institute team at Port Macquarie where he has been involved in the development of IMRT for breast, lung and gastrointestinal cancer.


Cancer genetics chair: A/Prof Judy Kirk

2011 - 2014

Associate Professor Judy Kirk is the director of the Familial Cancer Service at Westmead Hospital, a service that provides genetic counselling and testing for families with a strong family history of cancer. Judy has over 30 years' experience in cancer care. She has played a key role in setting national priorities and standards through clinical leadership, liaison with associated medical and surgical subspecialties, links with key cancer organisations and executive roles in preparation of NHMRC/NBOCC Clinical Practice Guidelines in this rapidly evolving field of medicine. She participates in local and national research regarding the familial aspects of cancer.


Cancer genetics chair: Margaret Gleeson

Nov 2011 - 2014

Margaret Gleeson is a cancer genetic counsellor with the Hunter Family Cancer Service in Waratah, Newcastle. She has a background in oncology nursing and over 17 years clinical experience in cancer genetics. Margaret has been involved in many related research projects, with her most recent being the issue of treatment focused genetic testing in breast and ovarian cancer.


Medical oncology chair: A/Prof Jeremy Shapiro

2015 - 2017, co-chair 2011 - 2014​

Dr Jeremy Shapiro is an associate professor in the Department of Medicine, Monash University and a gastrointestinal and genitourinary oncologist at the Alfred and Cabrini Hospitals in Melbourne. Dr Shapiro leads the GI research program at Cabrini Hospital, and is a senior researcher in the Australasian Gastrointestinal Trials Group, where he is the study co-chair for the Multinational AGITG Co20 and ICECREAM trials, evaluating novel approaches in advanced colon cancer.


Medical oncology chair: Dr Karen Briscoe

2011 - 2014, Co-chair 2009 - 2011

Dr Karen Briscoe has been a medical oncologist at a regional NSW cancer centre (Coffs Harbour) since 2004. Karen has experience in general oncology with a special interest in GIT/GU/lung. She has participated in clinical trials since establishing the clinical trials unit at Coffs Harbour in 2005. Karen has been a member of the eviQ reference committee since 2005.


Medical oncology chair: A/Prof Matthew Links

2009 - 2011, Co-chair 2005 - 2009

Associate Professor Mathew Links is a senior medical oncologist at St George Hospital Sydney, sub-specialising in lung cancer. He is the director advanced training for medical oncology in the South Eastern Sydney area and has had a long standing commitment to professional education and training. His research interests revolve around the integration of preclinical research, clinical trials, quality improvements, and education into improving outcomes for cancer patients. This encompasses a laboratory focus on the application of individualised medicine to drug combinations, through understanding the molecular basis of drug interactions; clinical trials focused on new therapies for lung cancer; and quality improvement through education.


Radiation oncology chair: A/Prof Thomas Shakespeare

2007 - 2011

Associate Professor Tom Shakespeare is the director of radiation oncology at the North Coast Cancer Institute, a large (6 linear accelerator) public radiotherapy centre that spans Lismore, Coffs Harbour and Port Macquarie in northern New South Wales. His special interests are image-guided intensity-modulated radiotherapy, prostate, breast and lung cancers. He is passionate about quality of patient care and patient-centred decision-making.


Radiation oncology chair: A/Prof Shalini Vinod

2012 - 2013

Associate Professor Shalini Vinod is a staff specialist in radiation oncology at the Liverpool Cancer Therapy Centre. She has over 10 years' clinical experience and has been involved in the eviQ radiation oncology reference group since inception. Shalini has been involved in writing clinical practice guidelines for gynaecological cancers and lung cancers at a statewide and national level. Her areas of research include multidisciplinary care in oncology and the use of new imaging modalities in radiotherapy.


Cancer genetics chair: Prof Robyn Ward

2008 - 2011
Medical oncology chair: 2005 - 2009
Haematology chair: 2005 - 2006

Professor Robyn Ward is a specialist medical oncologist, and is currently Deputy Vice-Chancellor (Research) and Acting Executive Dean of Medicine at the University of Queensland. She developed eviQ in 2000 and to this day remains as the program director of the site.